Publication

Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Sung-Whan Kim, Emory UniversityHong Lian Jin, Yonsei UniversitySeok-Min Kang, Yonsei UniversitySinyoung Kim, Yonsei UniversityKyung-Jong Yoo, Yonsei UniversityYangsoo Jang, Yonsei UniversityHyun Ok Kim, Yonsei UniversityYoung Sup Yoon, Emory University
Language
  • English
Date
  • 2016-01-15
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2015 Elsevier Ireland Ltd.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0167-5273
Volume
  • 203
Start Page
  • 498
End Page
  • 507
Grant/Funding Information
  • This work was supported in part by NIH grants DP3DK094346, R01 HL127759, Faculty Research Assistance Program of Yonsei University College of Medicine 2015, the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIP) (No. 2015M3A9C6031514) and a Grant from the Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (no. HI10C1740).
Supplemental Material (URL)
Abstract
  • Background: This study sought to systematically investigate the derivation of late outgrowth endothelial progenitor cells (late EPC) and mesenchymal stem cells (MSC) from umbilical cord blood (UCB) and to examine their therapeutic effects on myocardial infarction (MI). Methods: The expression of angiogenic genes were determined by qRT-PCR. Myocardial infarction (MI) was induced in rats, and cells were directly transplanted into the border regions of ischemic heart tissue. Results: Culture of UCB mononuclear cells yielded two distinct types of cells by morphology after 2 weeks in the same culture conditions. These cells were identified as late EPC and MSC, and each was intramyocardially injected into rat hearts after induction of MI. Echocardiography and histologic analyses demonstrated that both EPC and MSC improved cardiac function and enhanced vascularization, although fibrosis was reduced only in the EPC transplanted hearts. Different paracrine factors were enriched in EPC and MSC. However, once injected into the hearts, they induced similar types of paracrine factors in the heart. Transplanted EPC or MSC were mostly localized at the perivascular areas. This study demonstrated that EPC and MSC can be simultaneously derived from UCB under the same initial culture conditions, and that common paracrine factors are involved in the repair of MI. Conclusion: Late EPC and MSC are effective for infarct repair, apparently mediated through common humoral mechanisms.
Author Notes
  • Address correspondence to: Young-sup Yoon, MD, PhD, FAHA, Professor of Medicine, Director of Stem Cell Biology, Department of Medicine, Division of Cardiology, Emory University School of Medicine, 101 Woodruff Circle, WMB 3309, Atlanta, GA 30322, Severance Biomedical Science Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, Korea, Phone: 1-404-727-8176, yyoon5@emory.edu or Hyun-Ok Kim, Ph.D, Professor, Department of Laboratory Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, Korea, Phone: 82-2-2228-2444, Fax: 82-2-364-1583, Hyunok1019@yuhs.ac
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items